Phocas Financial Corp’s Bristol-Myers Squibb BMY Stock Holding History

Phocas Financial Corp’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,916	Closed	-$138K	–	202
2022 Q4	$138K	Buy	+1,916	New	+$144K	0.02%	200
2019 Q3	–	Sell	-1,400	Closed	-$63K	–	203
2019 Q2	$63K	Buy	+1,400	New	+$65.2K	0.01%	240
2019 Q1	–	Sell	-1,400	Closed	-$73K	–	208
2018 Q4	$73K	Buy	+1,400	New	+$75.2K	0.01%	230
2016 Q1	–	Sell	-3,197	Closed	-$220K	–	246
2015 Q4	$220K	Buy	+3,197	New	+$211K	0.02%	233
2015 Q3	–	Sell	-3,197	Closed	-$213K	–	213
2015 Q2	$213K	Hold	3,197	–	–	0.02%	244
2015 Q1	$206K	Buy	+3,197	New	+$200K	0.02%	242

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Phocas Financial Corp's BMY Position: Q1 2023 in Review

Phocas Financial Corp sold out of Bristol-Myers Squibb (BMY) in Q1 2023, closing a stake of 1,916 shares — an estimated $138K sold.

Phocas Financial Corp first reported a position in BMY in Q1 2015 and held it in 6 quarters. The position peaked at $220K in Q4 2015. 2,540 funds tracked by Wall St. Rank hold BMY as of Q1 2023.

Phocas Financial Corp reported no remaining Bristol-Myers Squibb position as of Q1 2023 after selling out during the quarter.
Phocas Financial Corp sold 1,916 Bristol-Myers Squibb shares in Q1 2023, an estimated $138K.
Phocas Financial Corp first reported a position in Bristol-Myers Squibb in Q1 2015 and held it in 6 quarters.
Phocas Financial Corp's Bristol-Myers Squibb position peaked at $220K in Q4 2015.
2,540 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2023.

Based on Phocas Financial Corp's 13F filing for Q1 2023, filed 13 Apr 2023.